Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures

J Am Acad Dermatol. 2021 Feb;84(2):432-470. doi: 10.1016/j.jaad.2020.07.087. Epub 2020 Jul 30.

Abstract

Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the United States population. This guideline addresses important clinical questions that arise in psoriasis management and care and provides recommendations based on the available evidence. The treatment of psoriasis with topical agents and with alternative medicine will be reviewed, emphasizing treatment recommendations and the role of dermatologists in monitoring and educating patients regarding benefits as well as risks that may be associated. This guideline will also address the severity assessment methods of psoriasis in adults.

Keywords: alternative medicine (AM); clinical guidelines for psoriasis; dermatology; guidelines; psoriasis; severity assessment; skin disease; topical agents.

Publication types

  • Practice Guideline

MeSH terms

  • Academies and Institutes / standards
  • Administration, Cutaneous
  • Combined Modality Therapy / methods
  • Combined Modality Therapy / standards
  • Complementary Therapies / methods*
  • Complementary Therapies / standards
  • Dermatologic Agents / administration & dosage*
  • Dermatology / methods*
  • Dermatology / standards
  • Evidence-Based Medicine / methods
  • Evidence-Based Medicine / standards
  • Foundations / standards
  • Humans
  • Patient Education as Topic / standards
  • Psoriasis / diagnosis
  • Psoriasis / therapy*
  • Severity of Illness Index
  • Treatment Outcome
  • United States

Substances

  • Dermatologic Agents